Analysts have differing opinions on the stock, with 4 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ICCM is 22.06M, and currently, short sellers hold a 1.28% ratio of that floaft. The average trading volume of ICCM on November 26, 2024 was 657.66K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ICCM) stock’s latest price update
Icecure Medical Ltd (NASDAQ: ICCM) has seen a rise in its stock price by 6.79 in relation to its previous close of 0.78. However, the company has experienced a 36.11% gain in its stock price over the last five trading sessions. zacks.com reported 2024-11-26 that IceCure Medical Ltd. (ICCM) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.07.
ICCM’s Market Performance
ICCM’s stock has risen by 36.11% in the past week, with a monthly rise of 25.76% and a quarterly rise of 27.18%. The volatility ratio for the week is 12.22% while the volatility levels for the last 30 days are 13.33% for Icecure Medical Ltd The simple moving average for the last 20 days is 18.52% for ICCM stock, with a simple moving average of -6.31% for the last 200 days.
ICCM Trading at 29.48% from the 50-Day Moving Average
After a stumble in the market that brought ICCM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -47.13% of loss for the given period.
Volatility was left at 13.33%, however, over the last 30 days, the volatility rate increased by 12.22%, as shares surge +9.62% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +33.59% upper at present.
During the last 5 trading sessions, ICCM rose by +40.21%, which changed the moving average for the period of 200-days by -38.49% in comparison to the 20-day moving average, which settled at $0.7017. In addition, Icecure Medical Ltd saw -22.43% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ICCM
Current profitability levels for the company are sitting at:
- -4.29 for the present operating margin
- 0.4 for the gross margin
The net margin for Icecure Medical Ltd stands at -4.07. The total capital return value is set at -1.34. Equity return is now at value -94.22, with -71.93 for asset returns.
Currently, EBITDA for the company is -15.25 million with net debt to EBITDA at 0.65. When we switch over and look at the enterprise to sales, we see a ratio of 8.83. The receivables turnover for the company is 10.45for trailing twelve months and the total asset turnover is 0.22. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.97.
Conclusion
In a nutshell, Icecure Medical Ltd (ICCM) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
